Jan 15 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's disease, a type of chronic ...
Drinking diet soda or sugary drinks daily may increase the risk of metabolic dysfunction-associated steatotic liver disease (MASLD), a study presented at the United European Gastroenterology ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する